Valion Bio annual current ratio
2021
2022
2023
2024
2025
Valion Bio Current Ratio Growth & History (VBIO)
Valion Bio's current ratio was 20.13 for fiscal 2025.
View full Valion Bio company overviewValion Bio annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 20.13 | 10.43 | +107.51% |
| 2024 | 2024-12-31 | 9.70 | 6.38 | +192.19% |
| 2023 | 2023-12-31 | 3.32 | 0.50 | +17.52% |
| 2022 | 2022-12-31 | 2.83 | −8.90 | −75.90% |
| 2021 | 2021-12-31 | 11.72 | — | — |
Valion Bio quarterly current ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.11 | −1.13 | −50.51% |
| Q1 2026 | 2026-03-31 | 3.31 | 1.61 | +94.42% |
| Q4 2025 | 2025-12-31 | 20.13 | 10.43 | +107.51% |
| Q3 2025 | 2025-09-30 | 5.86 | 0.21 | +3.79% |
| Q2 2025 | 2025-06-30 | 2.24 | −5.65 | −71.56% |
| Q1 2025 | 2025-03-31 | 1.70 | −1.15 | −40.29% |
| Q4 2024 | 2024-12-31 | 9.70 | 6.38 | +192.19% |
| Q3 2024 | 2024-09-30 | 5.65 | −0.81 | −12.50% |
| Q2 2024 | 2024-06-30 | 7.89 | 4.44 | +128.81% |
| Q1 2024 | 2024-03-31 | 2.85 | −1.27 | −30.84% |
| Q4 2023 | 2023-12-31 | 3.32 | 0.50 | +17.52% |
| Q3 2023 | 2023-09-30 | 6.46 | 2.70 | +71.96% |
| Q2 2023 | 2023-06-30 | 3.45 | −0.91 | −20.94% |
| Q1 2023 | 2023-03-31 | 4.12 | −6.82 | −62.32% |
| Q4 2022 | 2022-12-31 | 2.83 | −8.90 | −75.90% |
| Q3 2022 | 2022-09-30 | 3.75 | — | — |
| Q2 2022 | 2022-06-30 | 4.36 | — | — |
| Q1 2022 | 2022-03-31 | 10.94 | — | — |
| Q4 2021 | 2021-12-31 | 11.72 | — | — |
Valion Bio current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Valion Bio's current ratio increased from 11.72 to 20.13, a change of 8.41. The latest reported quarter, Q2 2026, shows 1.11.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Valion Bio source filings ↗